Besides these evidences, whether MDSCs and other types of immune cells are recruited into thyroid cancer microenvironment, and, if so, what pathological roles they are playing, or how activated BRAF/MAPK pathway regulates this process, remains to be explored. The gene discussed is BRAF; the disease is thyroid gland carcinoma.